News

Filter

Current filters:

USAGenerics

1 to 9 of 161 results

Mylan sales and revenue up while EpiPen becomes its first $1 billion-selling product

Mylan sales and revenue up while EpiPen becomes its first $1 billion-selling product

03-03-2015

US generic drugmaker Mylan has reported strong growth throughout the company for the fourth quarter and…

FinancialGenericsMylanPharmaceutical sciencesUSA

Actavis confirms generic Uceris patent challenge

Actavis confirms generic Uceris patent challenge

25-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that it has filed an Abbreviated New…

ActavisCosmo TechnologiesGastro-intestinalsGenericsPatentsRegulationSalix PharmaceuticalsSantarusUcerisUSAValeant Pharmaceuticals International

TWi Pharmaceuticals to use its own subsidiary in USA instead of Teva

24-02-2015

Generic drugmakers Taiwan-based TWi Pharmaceuticals and Israeli company Teva Pharmaceutical Industries…

GenericsLicensingLidodermMegace ESOncologyTeva Pharmaceutcal IndustriesTWi PharmaceuticalsUSA

Actavis receives final FDA approval for generic version of Subutex

Actavis receives final FDA approval for generic version of Subutex

22-02-2015

Ireland-headquartered generics major Actavis has received final approval from the US Food and Drug Administration…

Abbreviated New Drug ApplicationGenericsIndiviorNeurologicalRC PharmaceuticalsReckitt BenckiserRegulationSubutexUSA

Actavis’ fourth-qtr 2014 beats expectations

Actavis’ fourth-qtr 2014 beats expectations

18-02-2015

Ireland-headquartered generics major Actavis posted better-than-expected fourth-quarter and full-year…

AccountancyActavisAllerganFinancialForest LaboratoriesGenericsPharmaceuticalThomson ReutersUSA

Lupin links with Celon Pharma for generic Advair Diskus

Lupin links with Celon Pharma for generic Advair Diskus

18-02-2015

Indian drug major Lupin has entered into a definitive agreement with Polish drugmaker Celon Pharma to…

Advair DiskusCanadaCelon PharmaGenericsGlaxoSmithKlineLicensingLupinMarkets & MarketingMexicoRespiratory and PulmonaryUSA

AstraZeneca gets temporary injunction against Actavis over generic Pulmicort Respules

18-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that the US Court of Appeals for the…

ActavisAstraZenecaGenericsLegalPatentsPulmicort RespulesRespiratory and PulmonaryUSA

1 to 9 of 161 results

COMPANY SPOTLIGHT

Menarini

Back to top